Rasheduzzaman Chowdhury

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 9

Top Venues

Nature communications

ChemMedChem

Proteins

Chemical science

Stanford University School of Medicine

University of Oxford (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Stanford University School of Medicine

United States

Staff Scientist :: Molecular and Cellular Physiology

University of Oxford

United Kingdom

Research Scientist :: Chemistry - Chemical Biology

University of Oxford

United Kingdom

Postdoctoral Research Scientist :: Chemistry - Chemical Biology

University of Dhaka Faculty of Pharmacy

Bangladesh

Lecturer and Assistant Professor :: Pharmaceutical Chemistry

Education History

University of Oxford

United Kingdom

PHD :: Chemical and Structural Biology

University of Dhaka Faculty of Pharmacy

Bangladesh

MSC

Publications

William D Figg, Giorgia Fiorini, Rasheduzzaman Chowdhury, Yu Nakashima, Anthony Tumber, Michael A McDonough, Christopher J Schofield
Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2. Proteins (2023)
William D Figg, Michael A McDonough, Rasheduzzaman Chowdhury, Yu Nakashima, Zhihong Zhang, James P Holt-Martyn, Alen Krajnc, Christopher J Schofield
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat. ChemMedChem 16 (13) (2021)
James P Holt-Martyn, Anthony Tumber, Mohammed Z Rahman, Kerstin Lippl, William D Figg, Michael A McDonough, Rasheduzzaman Chowdhury, Christopher J Schofield
Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors. MedChemComm 10 (4) (2019)
Sarah E Wilkins, Md Saiful Islam, Joan M Gannon, Suzana Markolovic, Richard J Hopkinson, Wei Ge, Christopher J Schofield, Rasheduzzaman Chowdhury
JMJD5 is a human arginyl C-3 hydroxylase. Nature communications 9 (1) (2018)
Martine I Abboud, Tom E McAllister, Ivanhoe K H Leung, Rasheduzzaman Chowdhury, Christian Jorgensen, Carmen Domene, Jasmin Mecinovic, Kerstin Lippl, Rebecca L Hancock, Richard J Hopkinson, Akane Kawamura, Timothy D W Claridge, Christopher J Schofield
2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2. Chemical communications (Cambridge, England) 54 (25) (2018)
Sarah E Wilkins, Md Saiful Islam, Joan M Gannon, Suzana Markolovic, Richard J Hopkinson, Wei Ge, Christopher J Schofield, Rasheduzzaman Chowdhury
Publisher Correction: JMJD5 is a human arginyl C-3 hydroxylase. Nature communications 9 (1) (2018)
Tzu-Lan Yeh, Thomas M Leissing, Martine I Abboud, Cyrille C Thinnes, Onur Atasoylu, James P Holt-Martyn, Dong Zhang, Anthony Tumber, Kerstin Lippl, Christopher T Lohans, Ivanhoe K H Leung, Helen Morcrette, Ian J Clifton, Timothy D W Claridge, Akane Kawamura, Emily Flashman, Xin Lu, Peter J Ratcliffe, Rasheduzzaman Chowdhury, Christopher W Pugh, Christopher J Schofield
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials. Chemical science 8 (11) (2017)
Akane Kawamura, Martin Münzel, Tatsuya Kojima, Clarence Yapp, Bhaskar Bhushan, Yuki Goto, Anthony Tumber, Takayuki Katoh, Oliver N F King, Toby Passioura, Louise J Walport, Stephanie B Hatch, Sarah K Madden, Susanne Müller, Paul E Brennan, Rasheduzzaman Chowdhury, Richard J Hopkinson, Hiroaki Suga, Christopher J Schofield
Highly selective inhibition of histone demethylases by de novo macrocyclic peptides. Nature communications 8 (2017)
Louise J Walport, Richard J Hopkinson, Rasheduzzaman Chowdhury, Rachel Schiller, Wei Ge, Akane Kawamura, Christopher J Schofield
Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases. Nature communications 7 (2016)

Rasheduzzaman Chowdhury

Publication Activity (10 Years)

Top Topics

Top Venues